Kenneth Y. Usuki

Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001

Paul D. Brown, Vinai Gondi, Stephanie L. Pugh et al. · Journal of Clinical Oncology · 2020 · 830 citations · Full text

Medicine, Oncology, Radiation Oncology +14

Local control rates with five-fraction stereotactic body radiotherapy for oligometastatic cancer to the lung.

Deepinder Singh, Yuhchyau Chen, Mary Z. Hare et al. · PubMed · 2014 · 60 citations · Full text

Medicine, Oncology, Radiation Oncology +11

Preservation of Neurocognitive Function (NCF) with Conformal Avoidance of the Hippocampus during Whole-Brain Radiotherapy (HA-WBRT) for Brain Metastases: Preliminary Results of Phase III Trial NRG Oncology CC001

Vinai Gondi, S. Deshmukh, Paul D. Brown et al. · International Journal of Radiation Oncology*Biology*Physics · 2018 · 57 citations

Medicine, Oncology, Radiation Oncology +16

Sustained Preservation of Cognition and Prevention of Patient-Reported Symptoms With Hippocampal Avoidance During Whole-Brain Radiation Therapy for Brain Metastases: Final Results of NRG Oncology CC001

Vinai Gondi, Snehal Deshmukh, Paul D. Brown et al. · International Journal of Radiation Oncology*Biology*Physics · 2023 · 55 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Age-related differences in symptoms and their interference with quality of life in 903 cancer patients undergoing radiation therapy

Supriya G. Mohile, Charles E. Heckler, Karen M. Mustian et al. · Journal of Geriatric Oncology · 2011 · 51 citations · Full text

Medicine, Oncology, Radiation Oncology +16